Loading…
Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double‐blind controlled trial
Aims This trial was conducted to determine the efficacy of umbilical vein injection of 400 versus 800 μg misoprostol to deliver retained placenta and to compare both regimens regarding the time of placental delivery and amount of vaginal blood loss. Methods A double‐blind, multicenter randomized cli...
Saved in:
Published in: | The journal of obstetrics and gynaecology research 2020-05, Vol.46 (5), p.727-735 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims
This trial was conducted to determine the efficacy of umbilical vein injection of 400 versus 800 μg misoprostol to deliver retained placenta and to compare both regimens regarding the time of placental delivery and amount of vaginal blood loss.
Methods
A double‐blind, multicenter randomized clinical trial was undertaken in four teaching hospitals in the North of Iraq and Al‐Azhar University Hospital in Egypt, from March 2016 to May 2019. Group I (274 women) received 400 μg misoprostol and group II (249 women) received 800 μg misoprostol. Data regarding the time of placental separation and amount of vaginal blood loss were analyzed and proportions were compared between groups using Chi‐squared test. Mean values were compared using the Student's t‐test. The Mann–Whitney test was used to determine the median of vaginal blood loss.
Results
The proportion of placental separation was 84.3% among women in group I and 86.7% of women in group II. The mean time of placental separation was 18.86 ± 234.2 and 17.86 ± 213.09 min in groups I and II, respectively (P |
---|---|
ISSN: | 1341-8076 1447-0756 |
DOI: | 10.1111/jog.14232 |